Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 103Leukemia 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma 29Prostatic Neoplasms 28Leukemia, Monocytic, Acute 26Leukemia, Erythroblastic, Acute 23Congenital Abnormalities 23Leukemia, Myelomonocytic, Acute 22Leukemia, Megakaryoblastic, Acute 21Myelodysplastic Syndromes 17Lymphoma, Non-Hodgkin 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16Recurrence 14Lymphoma, Large-Cell, Immunoblastic 10Leukemia, Lymphocytic, Chronic, B-Cell 10Leukemia, Biphenotypic, Acute 9Lymphoma, Mantle-Cell 8Burkitt Lymphoma 7Breast Neoplasms 7Anemia, Refractory, with Excess of Blasts 6Neoplasms 5Leukemia, Promyelocytic, Acute 5Hodgkin Disease 5Blast Crisis 5Ovarian Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Eosinophilic, Acute 4Leukemia, Basophilic, Acute 4

Interventions

fludarabine 3Cyclophosphamide 3thymoglobulin 1prednylidene 1ofatumumab 1deltacortene 1daratumumab 1carmustine, poliferprosan 20 drug combination 1Telemedicine 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Melphalan 1Immunologic Tests 1Immunoglobulins, Intravenous 1Etoposide 1Data Collection 1Cytarabine 1Carmustine 1Blood Specimen Collection 1Antilymphocyte Serum 1Alleles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Autoimmune Diseases of the Nervous System × Mitoxantrone × Clear all
NCT00304291 2020-12-28

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

State University of New York at Buffalo

Phase 4 Completed
5 enrolled

Myelitis, Transverse, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS

Data powered by HemOnc (CC BY 4.0) Colophon âš¡